Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Haemophilus influenzae Type B Infections - Overview
Haemophilus influenzae Type B Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Haemophilus influenzae Type B Infections - Therapeutics Assessment
Assessment by Target
Assessment by Route of Administration
Assessment by Molecule Type
Haemophilus influenzae Type B Infections - Companies Involved in Therapeutics Development
AIM Vaccine Co Ltd
Biken Co Ltd
Biological E Ltd
CanSino Biologics Inc
Changchun Heber Biotechnology Co Ltd
Chengdu Olymvax Biopharmaceuticals Inc
Chongqing Zhifei Biological Products Co Ltd
Gritvak
KM Biologics Co Ltd
LG Chem Ltd
Liaoning Cheng Da Biotechnology Co Ltd
Novo Medi Sciences Pvt Ltd
Pacea Biotec Ltd
Serum Institute of India Pvt Ltd
Shantha Biotechnics Pvt Ltd
Suzhou Weichao Biotechnology Co Ltd
Wellstat Vaccines LLC
Yunn Watson Biotechnology Co Ltd
Haemophilus influenzae Type B Infections - Drug Profiles
(diphtheria + Haemophilus influenza [serotype B] + hepatitis B + pertussis + tetanus) (pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + haemophilus influenza [serotype B] + meningococcal + pertussis (acellular) + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] + pertussis (whole cell) + poliomyelitis + tetanus) (heptavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + Haemophilus influenzae [serotype B] + pertussis (acellular) + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + Haemophilus influenzae [serotype B] + pertussis (whole cell) + polio + tetanus)(pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + haemophilus influenzae [serotype B] + pertussis (whole cell) + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + tetanus + pertussis (acellular) + haemophilus influenzae [serotype B]) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + tetanus + pertussis (acellular) + haemophilus influenzae [serotype B]) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae [serotype B]) vaccine - Drug Profile
Product Description
Mechanism Of Action
(Haemophilus influenzae [serotype B] + meningococcal [serotypes A, C]) vaccine - Drug Profile
Product Description
Mechanism Of Action
(meningococcal [4-valent] + hemophilus influenzae [serotype B]) vaccine - Drug Profile
Product Description
Mechanism Of Action
BK-1310 - Drug Profile
Product Description
Mechanism Of Action
History of Events
haemophilus influenza B vaccine - Drug Profile
Product Description
Mechanism Of Action
haemophilus influenza B vaccine - Drug Profile
Product Description
Mechanism Of Action
haemophilus influenzae [serotype B] vaccine - Drug Profile
Product Description
Mechanism Of Action
haemophilus influenzae [serotype B] vaccine - Drug Profile
Product Description
Mechanism Of Action
haemophilus influenzae [serotype B] vaccine - Drug Profile
Product Description
Mechanism Of Action
Haemophilus influenzae B vaccine - Drug Profile
Product Description
Mechanism Of Action
Haemophilus influenzae B vaccine - Drug Profile
Product Description
Mechanism Of Action
KD-370 - Drug Profile
Product Description
Mechanism Of Action
History of Events
LR-20062 - Drug Profile
Product Description
Mechanism Of Action
Haemophilus influenzae Type B Infections - Dormant Projects
Haemophilus influenzae Type B Infections - Discontinued Products
Haemophilus influenzae Type B Infections - Product Development Milestones
Featured News & Press Releases
Apr 11, 2022: Marketing authorization application of pertussis, diphtheria, tetanus, ictivated polio and Hib combined vaccine (BK1310/MT-2355)
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Haemophilus influenzae Type B Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Haemophilus influenzae Type B Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Haemophilus influenzae Type B Infections - Pipeline by AIM Vaccine Co Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Biken Co Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Biological E Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by CanSino Biologics Inc, 2022
Haemophilus influenzae Type B Infections - Pipeline by Changchun Heber Biotechnology Co Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Chengdu Olymvax Biopharmaceuticals Inc, 2022
Haemophilus influenzae Type B Infections - Pipeline by Chongqing Zhifei Biological Products Co Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Gritvak, 2022
Haemophilus influenzae Type B Infections - Pipeline by KM Biologics Co Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by LG Chem Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Liaoning Cheng Da Biotechnology Co Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Novo Medi Sciences Pvt Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Panacea Biotec Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Serum Institute of India Pvt Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Shantha Biotechnics Pvt Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Suzhou Weichao Biotechnology Co Ltd, 2022
Haemophilus influenzae Type B Infections - Pipeline by Wellstat Vaccines LLC, 2022
Haemophilus influenzae Type B Infections - Pipeline by Yunnan Watson Biotechnology Co Ltd, 2022
Haemophilus influenzae Type B Infections - Dormant Projects, 2022
Haemophilus influenzae Type B Infections - Dormant Projects, 2022 (Contd..1)
Haemophilus influenzae Type B Infections - Discontinued Products, 2022